Elixinol Global Stock Forecast, Price & News

+0.01 (+3.57 %)
(As of 04/12/2021 03:44 PM ET)
Today's Range
Now: $0.15
50-Day Range
MA: $0.16
52-Week Range
Now: $0.15
Volume75,960 shs
Average Volume220,530 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Elixinol Global Ltd. engages in the sale of nutraceutical and related hemp products. It manufactures and distributes industrial hemp products and early stage medical cannabis business focusing on the importation, cultivation, manufacture and distribution of CBD and THC products. The firm operates through the following segments: The company was founded by Paul Benhaim on September 4, 2017 and is headquartered in Sydney, Australia.
Elixinol Global logo

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Phone(124) 044-4585
Year FoundedN/A



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable


Fog & Tree – Pioneering Cannabis Fragrance
February 10, 2021 |  benzinga.com
See More Headlines


Overall MarketRank

0.82 out of 5 stars

Medical Sector

1177th out of 2,016 stocks

Drug Manufacturers - Specialty & Generic Industry

21st out of 61 stocks

Analyst Opinion: 0.0Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
+0.01 (+3.57 %)
(As of 04/12/2021 03:44 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ELLXF News and Ratings via Email

Sign-up to receive the latest news and ratings for ELLXF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Elixinol Global (OTCMKTS:ELLXF) Frequently Asked Questions

What stocks does MarketBeat like better than Elixinol Global?

Wall Street analysts have given Elixinol Global a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Elixinol Global wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Elixinol Global?

Elixinol Global saw a decline in short interest in the month of March. As of March 15th, there was short interest totaling 1,000 shares, a decline of 74.4% from the February 28th total of 3,900 shares. Based on an average trading volume of 224,600 shares, the short-interest ratio is currently 0.0 days.
View Elixinol Global's Short Interest

How has Elixinol Global's stock been impacted by COVID-19 (Coronavirus)?

Elixinol Global's stock was trading at $0.20 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ELLXF stock has decreased by 27.5% and is now trading at $0.1450.
View which stocks have been most impacted by COVID-19

Who are Elixinol Global's key executives?

Elixinol Global's management team includes the following people:
  • Oliver Horn, Group Chief Executive Officer & Executive Director
  • Ron Dufficy, Chief Financial Officer
  • Greg Smith, Global Chief Information Officer
  • Tom Siciliano, Chief Executive Officer-Americas
  • Ali Atcha, Chief Executive Officer-Europe & United Kingdom

Who are some of Elixinol Global's key competitors?

What is Elixinol Global's stock symbol?

Elixinol Global trades on the OTCMKTS under the ticker symbol "ELLXF."

How do I buy shares of Elixinol Global?

Shares of ELLXF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Elixinol Global's stock price today?

One share of ELLXF stock can currently be purchased for approximately $0.15.

How many employees does Elixinol Global have?

Elixinol Global employs 76 workers across the globe.

What is Elixinol Global's official website?

The official website for Elixinol Global is www.elixinolglobal.com.

How can I contact Elixinol Global?

The company can be reached via phone at (124) 044-4585.

This page was last updated on 4/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.